Showing results (381-390 of 406) with videos related to
Sort By:
Pageof 41
Blood|June 30, 2021
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno ConsortiumSwantje Buchmann, Martin Schrappe, Andre Baruchel, et al.Leukemia|February 24, 2018
Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG)Sumit Gupta, Meenakshi Devidas, Mignon L Loh, et al.Journal of Medicinal Chemistry|January 27, 2016
Discovery of (R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a Potent and Selective Inhibitor of MET with High Unbound Target Coverage and Robust In Vivo Antitumor ActivityAlessandro A Boezio, Katrina W Copeland, Karen Rex, et al.Pediatric Blood & Cancer|February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conferenceTerzah M Horton, Richard Sposto, Patrick Brown, et al.Environmental Epidemiology (Philadelphia, Pa.)|July 19, 2024
Association between precipitation and mortality due to diarrheal diseases by climate zone: A multi-country modeling studyPaul L C Chua, Aurelio Tobias, Lina Madaniyazi, et al.Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitorsAlessandro A Boezio, Loren Berry, Brian K Albrecht, et al.American Journal of Hematology|February 18, 2022
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortiumLauren Pommert, Eric S Schafer, Jemily Malvar, et al.Elife|July 29, 2021
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strainsNikhil Faulkner, Kevin W Ng, Mary Y Wu, et al.Journal of Neurointerventional Surgery|April 5, 2020
Influence of thrombectomy volume on non-physician staff burnout and attrition in neurointerventional teamsKyle M Fargen, Sameer A Ansari, Alejandro Spiotta, et al.Journal of Hepatology|December 6, 2021
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver diseaseGeorg Semmler, Elias Laurin Meyer, Karin Kozbial, et al.Pageof 41